Advanced search
1 file | 922.87 KB Add to list

Adjusting for comorbidity in incidence-based DALY calculations: an individual-based modeling approach

Author
Organization
Abstract
Background. The co-occurrence of two or more medical conditions in the same individual is not uncommon. If disability-adjusted life year (DALY) calculations are carried out for each condition separately, multimorbidity may lead to an overestimation of the morbidity component, the Years Lived with Disability (YLD). Adjusting for comorbidity may be straightforward if all symptoms have same onset and duration; however, when the comorbid health states occur at different time points, an analytical solution to the comorbidity problem becomes more complex. The aim of this study was to develop an individual-based modelling (IBM) approach to adjust incidence-based disease burden estimation for multimorbidity that allows simulating hypothetical individuals and tracking their disease history, including possible comorbidities, over time. Methods. We demonstrated the IBM approach using an example of external comorbidity, i.e., colon cancer comorbid with healthcare-associated pneumonia (HAP) and by assuming an independent multiplicative model. First, each cumulative progression probabilities were converted to a daily transition probabilities. Second, disability weights for simultaneously experienced health states and duration in each health state were determined. Third, YLD, adjusted for comorbidity, was calculated at every time step. We simulated a cohort of 1000 colorectal cancer patients aged 65 years. Ninety-five percent uncertainty intervals around median YLD values were estimated by Monte Carlo methods. Results. The median estimated YLD per 1000 cases (due to both cancer and HAP) adjusted for co-morbidity was 545 YLD/1000 (95% interval: 513–585). The impact of not adjusting disability weights for co-existent health states varied from minimal to small; YLD for colorectal cancer would be overestimated only slightly – by 1.6 YLD/1000 – by not adjusting for concurrent HAP. YLD for those HAP patients who have concurrent early-stage colorectal cancer would be overestimated by 2.3 YLD/1000. Conclusions. The computation of disease burden in the presence of multimorbidity using the incidence-based DALY approach can be handled through IBM. Our approach can be extended to other, more complicated multimorbidity scenarios which are responsible for a high current global disease burden, such as tuberculosis and HIV infection.
Keywords
Burden of disease, Comorbidity, Multimorbidity

Downloads

  • mcdonald2020adjusting.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 922.87 KB

Citation

Please use this url to cite or link to this publication:

MLA
McDonald, Scott A., et al. “Adjusting for Comorbidity in Incidence-Based DALY Calculations: An Individual-Based Modeling Approach.” BMC Medical Research Methodology, vol. 20, 2020.
APA
McDonald, S. A., Haagsma, J. A., Cassini, A., & Devleesschauwer, B. (2020). Adjusting for comorbidity in incidence-based DALY calculations: an individual-based modeling approach. BMC Medical Research Methodology, 20.
Chicago author-date
McDonald, Scott A., Juanita A. Haagsma, Alessandro Cassini, and Brecht Devleesschauwer. 2020. “Adjusting for Comorbidity in Incidence-Based DALY Calculations: An Individual-Based Modeling Approach.” BMC Medical Research Methodology 20.
Chicago author-date (all authors)
McDonald, Scott A., Juanita A. Haagsma, Alessandro Cassini, and Brecht Devleesschauwer. 2020. “Adjusting for Comorbidity in Incidence-Based DALY Calculations: An Individual-Based Modeling Approach.” BMC Medical Research Methodology 20.
Vancouver
1.
McDonald SA, Haagsma JA, Cassini A, Devleesschauwer B. Adjusting for comorbidity in incidence-based DALY calculations: an individual-based modeling approach. BMC Medical Research Methodology. 2020;20.
IEEE
[1]
S. A. McDonald, J. A. Haagsma, A. Cassini, and B. Devleesschauwer, “Adjusting for comorbidity in incidence-based DALY calculations: an individual-based modeling approach,” BMC Medical Research Methodology, vol. 20, 2020.
@article{8660986,
  abstract     = {Background. The co-occurrence of two or more medical conditions in the same individual is not uncommon. If disability-adjusted life year (DALY) calculations are carried out for each condition separately, multimorbidity may lead to an overestimation of the morbidity component, the Years Lived with Disability (YLD). Adjusting for comorbidity may be straightforward if all symptoms have same onset and duration; however, when the comorbid health states occur at different time points, an analytical solution to the comorbidity problem becomes more complex. The aim of this study was to develop an individual-based modelling (IBM) approach to adjust incidence-based disease burden estimation for multimorbidity that allows simulating hypothetical individuals and tracking their disease history, including possible comorbidities, over time.

Methods. We demonstrated the IBM approach using an example of external comorbidity, i.e., colon cancer comorbid with healthcare-associated pneumonia (HAP) and by assuming an independent multiplicative model. First, each cumulative progression probabilities were converted to a daily transition probabilities. Second, disability weights for simultaneously experienced health states and duration in each health state were determined. Third, YLD, adjusted for comorbidity, was calculated at every time step. We simulated a cohort of 1000 colorectal cancer patients aged 65 years. Ninety-five percent uncertainty intervals around median YLD values were estimated by Monte Carlo methods.

Results. The median estimated YLD per 1000 cases (due to both cancer and HAP) adjusted for co-morbidity was 545 YLD/1000 (95% interval: 513–585). The impact of not adjusting disability weights for co-existent health states varied from minimal to small; YLD for colorectal cancer would be overestimated only slightly – by 1.6 YLD/1000 – by not adjusting for concurrent HAP. YLD for those HAP patients who have concurrent early-stage colorectal cancer would be overestimated by 2.3 YLD/1000.

Conclusions. 
The computation of disease burden in the presence of multimorbidity using the incidence-based DALY approach can be handled through IBM. Our approach can be extended to other, more complicated multimorbidity scenarios which are responsible for a high current global disease burden, such as tuberculosis and HIV infection.},
  articleno    = {100},
  author       = {McDonald, Scott A. and Haagsma, Juanita A. and Cassini, Alessandro and Devleesschauwer, Brecht},
  issn         = {1471-2288},
  journal      = {BMC Medical Research Methodology},
  keywords     = {Burden of disease,Comorbidity,Multimorbidity},
  language     = {eng},
  title        = {Adjusting for comorbidity in incidence-based DALY calculations: an individual-based modeling approach},
  url          = {http://dx.doi.org/10.1186/s12874-020-00987-z},
  volume       = {20},
  year         = {2020},
}

Altmetric
View in Altmetric